The Kores Group
Pharmaceutical & Chemical Division
CIN: U21198MH1936PLC002494

Pharmaceutical Intermediates We Manufacture

Name CAS # For End Use
3-Methylxanthine 1076-22-8 Linagliptin , Propentofylline
8-Bromo-3-methyl xanthine 93703-24-3 Linagliptin
2-Chloromethyl-4-methyl-quinazoline 109113-72-6 Linagliptin
8-Bromo-3-methyl-7-but-2-ynyl xanthine 666816-98-4 Linagliptin
6-Chloro-3-methyluracil 4318-56-3 Alogliptin
6-Chloro-1,3-dimethyluracil 6972-27-6 Urapidil
6-Amino-1-methyl-5-propylaminouracil 125092-42-4 Urapidil
1,3-Dimethyl-6-(3-chloropylamine) uracil 34654-81-4 Urapidil
3,5-(2-Methylpropionitrilo) benzylbromide 120511-84-4 Anastrozole
3,5-(2-Methylpropionitrilo) toluene 120511-72-0 Anastrozole
1-Methylbenzene-3,5-diacetonitrile 120511-74-2 Anastrozole
2-Amino-3,5-dirbomobenzaldehyde 50910-55-9 Ambroxol
S(-) – 2-amino-4,5,6,7-tetrahydro-6-aminobenzothiazole 106092-09-5 Pramipexole
2,6-Diamino-4,5,6,7-tetrahydrobenzothiazole 104617-49-4 Pramipexole
4-Phthalimidocyclohexanone 104618-32-8 Pramipexole
2-Methyl benzhydrol 5472-13-9 Orphenadrine
2-Methyl benzhydryl Chloride 41870-52-4 Orphenadrine
8-Chloro Theophylline 85-18-7 Dimenhydrinate & Promethazine teoclate
8-Benzyl Theophylline 2879-15-4 Bamifylline
8-Bromo Theophylline 10381-75-6 Pamabrom
3-Methyl-7-n-propyl xanthine 55242-64-3 Propentofylline
Theobromine 83-67-0 Pentoxifylline
6-Amino-1,3-dimethyluracil 6642-31-5 Pharmaceutical Intermediate

Also See : Active Pharmaceutical Ingredients

Products with valid Patents not offered for sale